Juul Settles with Iowa Over Underage Marketing

Dec.29.2022
Juul Settles with Iowa Over Underage Marketing
Juul, a major US e-cigarette manufacturer, will pay $5m and improve its advertising to settle claims of targeting minors in Iowa.

Juul, the largest electronic cigarette manufacturer in the United States, has agreed to improve its advertising and retail practices in Iowa and pay $5 million over the course of four years to resolve allegations of violating state laws.


Iowa's Attorney General Tom Miller announced a settlement with Juul to resolve potential violations of Iowa's Deceptive Trade Practices Act.


Miller claims that targeting individuals under the age of 21 in Iowa is a violation of state law, and is a focus of their company's products.


In a statement, Miller said, "The agreement strikes a balance in the truthful advertising and promotion of Juul e-cigarette devices and pods. E-cigarettes should be marketed to smokers as a less harmful alternative, but not to young people.


As part of an agreement, Juul has agreed to annually send $1.25 million to the Iowa Department of Public Health. The funds will be used to provide resources and education to youth under the age of 21 in Iowa, including assistance with smoking cessation.


The company denies any wrongdoing and additionally agrees to: [insert other terms here].


Do not target young people in Iowa through advertising, promotions, or marketing of Juul products.


Individuals are required to conduct age verification on any website they own or operate.


Do not display Juul products in retail stores outside of the counter area, and customers are not allowed to access the products with the assistance of employees.


Online transactions will be limited to a maximum of two Juul devices per month, ten Juul devices per year, and 60 Juul pods per month.


Taking reasonable measures, retail transactions in Iowa are limited to one Juul device or 16 Juul pods per transaction.


Do not sell products to consumers under the age of 21.


Disclose the nicotine content in their products.


The company has also agreed to appoint a designated staff member to ensure compliance with the agreement with the Iowa Attorney General's office and to address any compliance-related issues.


In 2018, Juul Labs sought guidance from Miller on using their product as a means to reach young people. Miller was employed as part of these efforts.


In April 2018, this electronic cigarette manufacturer announced that, as part of a $30 million initiative over the next three years, it will support efforts by states and the federal government to raise the minimum age for purchasing tobacco products. The initiative amounts to approximately 210 million yuan.


Part of the funding includes a research team led by former Attorney General and public health officials, convened by Miller, who has ties to the tobacco industry.


A spokesperson for the Office of the Attorney General stated, "The consulting group was independent from Juul, and its members did not receive any form of compensation. The group's recommendations to Juul were similar to the final settlement agreement. The consulting group disbanded at the end of 2018.


In 1998, Miller and other 45 state attorneys general signed a settlement agreement with the four major tobacco companies in the United States to resolve lawsuits related to state healthcare costs associated with smoking-related illnesses.


This agreement is the largest of its kind in American history, requiring companies to pay $206 billion over 25 years to 46 states, followed by annual payments based on national cigarette sales.


Over the past 24 years, the state has received more than $1.41 billion (approximately RMB 9.84 billion) in payments as part of the peace agreement.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Sweden's Supreme Administrative Court has declined to hear an appeal over age verification for tobacco and nicotine products collected from parcel lockers, leaving in place a lower-court ruling that geo-located BankID verification is insufficient to securely verify the actual recipient. Haypp Group has stopped tobacco and nicotine sales through Snusnetto and is deploying a new system across its other Swedish e-commerce sites to verify the age of the person who actually opens the locker and receives the shipment. The change comes as age verification across next-generation nicotine products expands from purchase checks into retail, delivery and, for some e-cigarettes, device access itself.
Regulations
Oct.20
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13